Key facts
- It has raised $19.7M across 3 recorded rounds; the latest was Early Stage VC ($8.3M) in Nov 2021.
- Trace Genomics has filed 5 Form Ds with the SEC since 2018, most recently Nov 2021 ($8.3M sold to 8 investors).
Free account
See the evidence behind this price
- ·Post-money valuations for all 3 rounds
- ·Watchlist + deal alerts for Trace Genomics
Create free account
No card required
Funding rounds
3 roundsDec 2018Early Stage VC (Series A)$19.7M▮
About Trace Genomics
- Industry
- Media and Information Services (B2B)
PA Mark — not yet priced
Trace Genomics doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Pro members can request priority coverage with a 48-hour turnaround.
Recorded secondary trades
No prints on record
No secondary trades in Trace Genomics shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Pro members can request priority coverage with a 48-hour turnaround.
Institutional fund marks
No fund marks yet
No SEC-registered fund has reported a fair-value mark on Trace Genomics in its N-PORT filings yet. We sweep new filings monthly.
Pro members can request priority coverage with a 48-hour turnaround.